![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Overcoming 5 of the most prominent challenges in lentiviral vector development and manufacturing
Genezen Online Topics
Viral vectors play a vital role in the development of cell and gene therapies (C>s). By delivering genetic material to patients’ cells to replace dysfunctional or damaged DNA, these complex tools have helped to...
Room for All: Opportunities for Gender Diversity Within the Health Tech Industry
Doceree Inc Online Topics
The healthcare industry has undergone evident transformations in the past ten years. Innovations involving artificial intelligence (AI) driven technologies have uplifted diagnostics and aftercare, and have improved patient experience significantly. Furthermore, investments in health...
Aiming for balance in a conflicted world
Vetter Online Topics
With sustainability as a daily challenge and energy in short supply, a dependable management plan is essential
If someone asks me today, “As an executive in the biopharma industry, what are the issues that keep...
Optimizing cold chain and fill-finish capabilities for the coming wave of mRNA technologies
Samsung Biologics Print Issue December 2022
Reacting rapidly after the initial onset of the pandemic the biopharma industry accelerated its research into advanced anti-viral modalities including messenger RNA (mRNA) vaccines. As the pharma industry’s leaders responded to the crisis, the...
Transforming the clinical data management process with Agile
Tata Consultancy Services Limited Online Topics
Introduction
The clinical research industry wants to achieve the common goal of accelerating drug development by improving the process of data collection, data validation, analysis, and submission. Faster time to market puts pressure on every...
Biopharma 2022: 5 Trends Shaping the Industry
Vetter Print Issue December 2022
Just 10 months ago, pharma and biotech companies rode a wave of pandemic-driven innovation and historic funding levels into what many hoped would be another banner year. Now, after several quarters of shifting expectations,...
How to plan cGMP-compliant clinical batches
Vetter Online Topics
For companies developing new injectable medications, manufacturing issues have become one of the greatest and most consistent early stumbling blocks. In fact, the FDA has issued more than 600 manufacturing citations in just the...
The future of high-throughput screening
Bruker Corporation Print Issue August 2022
High-throughput screening (HTS) is a method for drug discovery that allows automated testing of large numbers of chemical and biological compounds for a specific biological target. Mass spectrometry is particularly appealing for HTS as...
Converting Injectable Therapies to Combination Drug-Device Products
Vetter Online Topics
How to seize market opportunities while navigating the requirements of both drug therapies and delivery devices
The global biopharma market has recently experienced a remarkable period of evolution and expansion. In that time, parenteral medications...
Soft mist nasal sprays ready to take the sting out of vaccine delivery
Recipharm Print Issue August 2022
The COVID-19 pandemic delivered many valuable lessons to the pharmaceutical industry, and emphasised the benefits of preparing for future pandemics. Wilbur de Kruijf at Recipharm argues how vaccines optimised for delivery by nasal administration...